Pamissel has ranked among the top searched stocks for 16 days in the past month.


As of 9:30 AM on the 29th, Pamissel is trading at 16,800 KRW, up 1.82% from the previous day. This is a 13.85% decrease compared to October 6. Pamissel is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.


Over the past five days, individual investors have net purchased 26,440 shares, while foreigners and institutions have net purchased 77,830 shares and net sold 112,312 shares, respectively.


On October 25, Pamissel was a market topic with the headline "Rising Close on FDA Approval of Remdesivir in the US."


※ Source: AI Investment Assistant AI Lassi


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing